Gator Bio
Focus: Gator Bio develops next-generation bioluminescent imaging (BLI) technology with enhanced signal strength, wider detection range, and superior regeneration capabilities for oncology research and applications.
Profile data last refreshed 15h ago · AI intelligence enriched 2w ago
Open Jobs
1-3 this month
Stable — net -3 jobs in 30d
2 added, 5 removed. Backfill posture.
Should You Work at Gator Bio?
AI assessmentGator Bio is a high-risk, high-reward early-stage play best suited for career-building candidates willing to bet on proprietary technology differentiation in a pre-commercial phase.
Why Work Here
- Early-stage opportunity to shape a deep-tech platform with proprietary BLI advantages in high-demand oncology space
- Located in Palo Alto innovation hub with access to top-tier talent and venture capital ecosystem
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Interview Prep Quick Facts
Help build intelligence for Gator Bio
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.